Liarozole
Liarozole Basic information
- Product Name:
- Liarozole
- Synonyms:
-
- Liarozole
- 6-((3-chlorophenyl)(1H-imidazol-1-yl)methyl)-1H-benzo[d]imidazole
- 1H-Benzimidazole, 6-[(3-chlorophenyl)-1H-imidazol-1-ylmethyl]-
- Retinoic acid receptors,Mesenchymal,R 75251,RAR/RXR,CYPs,Retinoid X receptors,R-75251,Imidazole,Ovariectomized,R75251,MCF-7,Liarozole,Cytochrome P450,Inhibitor,inhibit,SCID,Hydroxylation
- Liarozole, 10 mM in DMSO
- CAS:
- 115575-11-6
- MF:
- C17H13ClN4
- MW:
- 308.76
- Mol File:
- 115575-11-6.mol
More
Less
Liarozole Chemical Properties
- Melting point:
- 108.2°
- Boiling point:
- 578.2±40.0 °C(Predicted)
- Density
- 1.36±0.1 g/cm3(Predicted)
- solubility
- DMSO: soluble
- form
- A solid
- pka
- 12.36±0.10(Predicted)
- color
- Off-white to light yellow
More
Less
Liarozole Usage And Synthesis
Uses
Antipsoriatic.
Definition
ChEBI: Liarozole is a member of benzimidazoles.
brand name
Liazal(Janssen).
in vivo
Liarozole (5-20 mg/kg; p.o.; 3 days) reverses the vaginal keratosis caused by estrogen stimulation[5].
Liarozole (40 mg/kg; p.o.; 21 days) reduces tumor burden substantially[6].
| Animal Model: | Ovariectomized rats[5] |
| Dosage: | 5~20 mg/kg |
| Administration: | P.o.; 3 days |
| Result: | Reversed the vaginal keratosis caused by estrogen stimulation. |
| Animal Model: | SCID mice[6] |
| Dosage: | 40 mg/kg |
| Administration: | P.o.; 21 days |
| Result: | Inhibited tumor growth and survival. |
IC 50
CYP26: 7 μM (IC50)
LiarozoleSupplier
LGM Pharma
- Tel
- 1-(800)-881-8210
- inquiries@lgmpharma.com
Shanghai EFE Biological Technology Co., Ltd.
- Tel
- 021-65675885 18964387627
- info@efebio.com
Shanghai YuanYe Biotechnology Co., Ltd.
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
Tianjin Kailiqi Biotechnology Co., Ltd.
- Tel
- 15076683720
- klq@cw-bio.com
TargetMol Chemicals Inc.
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com